Hypometabolism in the brain increases risk of Alzheimer disease (AD)
Semaglutide and nonarteritic anterior ischaemic optic neuropathy
(17) Semaglutide was found to enhance bone formation through the upregulation of osteogenic pathways- specifically -catenin via the Wnt signaling pathway
In 1964, the development of insulin radioimmunoassay methods led to the discovery of the incretin effect, which demonstrated that oral glucose intake induces higher insulin secretion compared to intravenous (i.v.) glucose [3,4]
This capability is especially relevant because flavonoid biosynthesis is tightly integrated with hormonal signaling, ROS homeostasis, and defense-associated transcriptional cascades
These adverse side effects include sudden blindness (NAION), gastroparesis (a dangerously slowed gut), and pancreatitis